George Hill
Stock Analyst at Deutsche Bank
(4.54)
# 1,022
Out of 5,043 analysts
627
Total ratings
54%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Reiterated: Buy | $875 → $913 | $938.84 | -2.75% | 68 | Oct 6, 2026 | |
| CLOV Clover Health Investments | Initiated Coverage: Buy | $6 | $4.79 | +25.26% | 1 | Sep 11, 2026 | |
| HQY HealthEquity | Rated: Buy | $128 → $142 | $92.61 | +53.33% | 25 | Aug 31, 2026 | |
| CAH Cardinal Health | Reiterated: Hold | $261 | $237.57 | +9.86% | 48 | Aug 13, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | $3 → $1 | $0.98 | +2.04% | 14 | Aug 12, 2026 | |
| HIMS Hims & Hers Health | Rated: Hold | $25 → $26 | $30.92 | -15.91% | 16 | Aug 11, 2026 | |
| EHTH eHealth | Reiterated: Hold | $3 → $2 | $0.70 | +185.71% | 24 | Aug 6, 2026 | |
| UNH UnitedHealth Group | Reiterated: Hold | n/a | $379.30 | - | 38 | Aug 3, 2026 | |
| CI The Cigna Group | Reiterated: Hold | $302 → $305 | $282.43 | +7.99% | 31 | Jul 31, 2026 | |
| WAY Waystar Holding | Rated: Buy | $37 → $39 | $26.68 | +46.18% | 5 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $441 → $436 | $431.87 | +0.96% | 38 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $39 → $80 | $65.36 | +22.40% | 23 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $332 → $498 | $412.70 | +20.67% | 20 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $33 → $49 | $82.39 | -40.53% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $86.16 | +6.78% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $109 → $129 | $196.93 | -34.49% | 24 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $12 → $11 | $5.77 | +90.64% | 41 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $3 | $3.43 | -12.54% | 18 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $322 → $371 | $323.85 | +14.56% | 38 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $295 → $210 | $164.17 | n/a | 11 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $5 | $5.09 | n/a | 32 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $175 | $276.47 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $250 | $259.88 | n/a | 20 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $409 → $350 | $301.79 | n/a | 16 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $34.25 | n/a | 1 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $91 | $84.01 | n/a | 1 | Sep 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $129.64 | n/a | 1 | Oct 6, 2011 |
McKesson
Oct 6, 2026
Reiterated: Buy
Price Target: $875 → $913
Current: $938.84
Upside: -2.75%
Clover Health Investments
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $4.79
Upside: +25.26%
HealthEquity
Aug 31, 2026
Rated: Buy
Price Target: $128 → $142
Current: $92.61
Upside: +53.33%
Cardinal Health
Aug 13, 2026
Reiterated: Hold
Price Target: $261
Current: $237.57
Upside: +9.86%
Definitive Healthcare
Aug 12, 2026
Reiterated: Hold
Price Target: $3 → $1
Current: $0.98
Upside: +2.04%
Hims & Hers Health
Aug 11, 2026
Rated: Hold
Price Target: $25 → $26
Current: $30.92
Upside: -15.91%
eHealth
Aug 6, 2026
Reiterated: Hold
Price Target: $3 → $2
Current: $0.70
Upside: +185.71%
UnitedHealth Group
Aug 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $379.30
Upside: -
The Cigna Group
Jul 31, 2026
Reiterated: Hold
Price Target: $302 → $305
Current: $282.43
Upside: +7.99%
Waystar Holding
Jul 31, 2026
Rated: Buy
Price Target: $37 → $39
Current: $26.68
Upside: +46.18%
Jul 30, 2026
Reiterated: Buy
Price Target: $441 → $436
Current: $431.87
Upside: +0.96%
May 20, 2026
Upgraded: Buy
Price Target: $39 → $80
Current: $65.36
Upside: +22.40%
May 20, 2026
Upgraded: Buy
Price Target: $332 → $498
Current: $412.70
Upside: +20.67%
May 7, 2026
Upgraded: Buy
Price Target: $33 → $49
Current: $82.39
Upside: -40.53%
May 7, 2026
Reiterated: Buy
Price Target: $92
Current: $86.16
Upside: +6.78%
Apr 24, 2026
Reiterated: Hold
Price Target: $109 → $129
Current: $196.93
Upside: -34.49%
Mar 10, 2026
Upgraded: Buy
Price Target: $12 → $11
Current: $5.77
Upside: +90.64%
Feb 27, 2026
Reiterated: Hold
Price Target: $6 → $3
Current: $3.43
Upside: -12.54%
Nov 7, 2025
Reiterated: Buy
Price Target: $322 → $371
Current: $323.85
Upside: +14.56%
Jul 29, 2025
Reiterated: Buy
Price Target: $295 → $210
Current: $164.17
Upside: n/a
Mar 27, 2025
Reiterated: Hold
Price Target: $10 → $5
Current: $5.09
Upside: n/a
Jun 28, 2024
Reiterated: Hold
Price Target: $175
Current: $276.47
Upside: n/a
Mar 22, 2022
Reiterated: Buy
Price Target: $255 → $250
Current: $259.88
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $409 → $350
Current: $301.79
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: $68
Current: $34.25
Upside: n/a
Sep 19, 2017
Initiated Coverage: Hold
Price Target: $91
Current: $84.01
Upside: n/a
Oct 6, 2011
Upgraded: Buy
Price Target: n/a
Current: $129.64
Upside: n/a